Patent 5721214 Issued on February 24, 1998. Estimated Expiration Date: June 7, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
514/18, 3 or 4 peptide repeating units in known peptide chain514/19, 2 peptide repeating units in known peptide chain530/331Tripeptides, e.g., tripeptide thyroliberin (TRH), melanostatin (MIF), etc.
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.
Other References
Ohta et al., "Interaction of Antistasin-related Peptides with Factor Xa: Identification of a Core Inhibitory Sequence", Thrombosis and Haemostasis 72 (6) 825-830 (1994)
Almquist, R.G., et al., J Med Chem (1980) 23:1392-1398 (--COCH2 --)
Angelastro, et al., J. Med. Chem., 33,11-13 (1990)
Blankenship, D.T. et al., "Amino Acid Sequence of Ghilanten: Anti-coagulant-antimetastatic Principle of the South American Leech, Haementeria ghilianii," Biochem. Biophys. Res. Commun. 166, 1384-1389 (1990)
Brankamp, R.G. et al., "Ghilantens: Anticoagulants, Antimetastatic Proteins from the South American Leech Haementeria ghilianii," J. Lab. Clin. Med., 15, 89-97 (1990)
Bundgard, H., Design of Prodrugs, pp. 7-9, 21-24, Elsevier, Amsterdam 1985
CA:97:39405 (1982) (--CH(OH)CH2 --)
Cappello, M. et al., "Ancylostoma Factor Xa Inhibitor: Partial Purification and its Identification as a Major Hookworm-derived Anticoagulant In Vitro," J. Infect. Dis., 167, 1474-1477 (1993)
Claeson, G., "Synthetic Peptides and Peptidomimetics as Substrates and Inhibitors of Thrombin and Other Proteases in the Blood Coagulation System," Blood Coag. Fibrinol. 5, 411-436 (1994)
Condra, C. et al., "Isolation and Structural Characterization of a Potent Inhibitor of Coagulation Factor Xa from the Leech Haementeria ghilianii," Thromb. Haemost., 61, 437-441 (1989)
Cox, A.C., "Coagulation Factor X Inhibitor From the Hundred-pace Snake Deinagkistrodon acutus, venom," Toxicon, 31, 1445-1457 (1993)
Davie, E.J., et al., "The Coagulation Cascade: Initiation, Maintenance and Regulation," Biochemistry 30, 10363-10370 (1991)
Etingin, O.R., et al., Cell, 61, 657 (1990)
Furie, B., et al., Cell, 53, 505 (1988)
Girard, T.J. et al., "Functional Significance of the Kunitz-type Inhibitory Domains of Lipoprotein-associated Coagulation Inhibitor," Nature, 338, 518-520 (1989)
Hann, M.M., J Chem Soc Perkin Trans I (1982) 307-314 (--CH.dbd.CH--, cis and trans)
Hauptmann, J. et al., "Comparison of the Anticoagulant and Antithrombotic Effects of Synthetic Thrombin and Factor Xa Inhibitors," Thromb. Haemost, 63, 220-223 (1990)
Hitomi, Y. et al., "Inhibitory Effect of New Synthetic Protease Inhibitor (FUT-175) on the Coagulation System," Haemostasis, 15, 164-168 (1985)
Holladay, M.W. et al., Tetrahedron Lett (1983) 24:4401-4404 (--C(OH)CH2 --)
Hollenbach, S. et al., Thromb. Haemost. 71, 357-362 (1994)
Hoover, R.J. et al., Cell, 4, 423 (1978)
Hruby, V.J., Life Sci (1982) 31:189-199 (--CH2 --S--)
Hudson, D., et al., Int J Pept Prot Res (1979) 14:177-185 (--CH2 NH-, -CH2 CH2 --)
Jacobs, J.W. et al., "Isolation and Characterization of a Coagulation Factor Xa Inhibitor from Black Fly Salivary Glands," Thromb. Haemost., 64, 235-238 (1990)
Jennings-White, C., et al., Tetrahedron Lett (1982) 32:2533 (--COCH2 --)
Kam, C.M. et al., "Mechanism Based Isocoumarin Inhibitors for Trypsin and Blood Coagulation Serine Proteases: New Anticoagulants," Biochemistry, 27, 2547-2557 (1988)
Kettner, C. et al., J. Biol. Chem. 265, 18289-18297 (1990)
Medhi, G. et al., Biochem. Biophys. Res. Commun., 166, 595-600 (1990)
Morley, J.S., Trends Pharm Sci (1980) pp. 463-468 (general review)
Nagahara, T. et al., "Dibasic (Amidinoaryl)propanoic Acid Derivaties as Novel Blood Coagulation Factor Xa Inhibitors," J. Med. Chem., 37, 1200-1207 (1994)
Nutt, E. et al., "The Amino Acid Sequence of Antistasin, a Potent Inhibitor of Factor Xa Reveals a Repeated Internal Structure," J. Biol. Chem., 263, 10162-10167 (1988)
Seymour, J.L. et al., "Ecotin is a Potent Anticoagulant and Reversible Tight-binding Inhibitor of Factor Xa," Biochemistry 33, 3949-3958 (1994)
Silverman, R.B., The Organic Chemistry of Drug Design and Drug Action, pp. 352-401, Academic Press, San Diego, CA 1992
Sinha, U. et al., Thromb. Res., 75, 427-436 (1994)
Skiles, J.W. et al., J. Med. Chem. 35 , 641-662 (1992)
Spatola, A.F., in "Chemistry and Biochemistry of Amino Acids, Peptides and Proteins," B. Weinstein, eds., Marcel Dekker, New York, pp. 267-355 (1983) (general review)
Spatola, A.F., et al., Life Sci (1986) 38:1243-1249 (--CH2 --S)
Sturzebecher, J. et al., "Synthetic Inhibitors of Bovine Factor Xa and Thrombin. Comparison of Their Anticoagulant Efficiency," Thromb. Res., 54, 245-252 (1989)
Tapparelli et al., J. Biol. Chem. 268, 4734-4741 (1993)
Tidwell, R.R. et al., "Strategies for Anticoagulation With Synthetic Protease Inhibitors. Xa Inhibitors Versus Thrombin Inhibitors," Thromb Res.19, 339-349 (1980)
Turner, A.D., et al., "p-Amidino Esters as Irreversible Inhibitors of Factor IXa and Xa and Thrombin," Biochemistry, 25, 4929-4935 (1986)
Waxman, L. et al., "Tick Anticoagulant Peptide (TAP) is a Novel Inhibitor of Blood Coagulation Factor Xa" Science, 248, 593-596 (1990)
Bajusz, Sandor, et al. Design and Synthesis of Peptide Inhbitors of Blood Coagulation, Folia Haematol. (Leipzig), 109 (1), 16-21,198
June 7, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
